Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’ve been posting on a few boards Dr Phil. Couldn’t remember which one I sent that on. Had lots of beverages over the weekend so maybe it was... regardless!!!!! How ya doing today!!!!! You’ve been quiet the last few days with your tail tucked and now you finally replied,,,,,, I’m ready for more battles with you.... Don’t loose faith in me yet$$$$$$$$$ May is around the corner.... U still believe this stock is garage? That’s when I’m walking y’all or finding your closet to tuck my tail inn with ya buddy’s
Great hearing from you
What will be the big stories on Thursday when Gilead announces its first-quarter results? Here are three things you can expect with the company's Q1 update.
Businessman looking through binoculars with dollar signs in the lenses
IMAGE SOURCE: GETTY IMAGES.
1. A lot of focus on remdesivir
Earnings, shmearnings. What everybody really wants to hear about is Gilead's antiviral drug remdesivir. It's a pretty safe bet that you'll hear plenty from the company about its experimental COVID-19 candidate in its Q1 update.
Gilead CEO Dan O'Day has previously stated that the biotech would have preliminary results from a late-stage study of remdesivir in treating patients with severe cases of COVID-19 by the end of April and would "work quickly to interpret and share the findings." The company's conference call will coincidently occur on the last day of the month. It's possible if not probable that Gilead will provide an update from its study then.
Investors have had reasons for both optimism and pessimism about remdesivir's prospects in recent days. On April 17, STAT reported that the drug appeared to be successful in treating patients with severe cases of COVID-19 in Gilead's study being conducted at the University of Chicago. Nearly a week later, a draft summary of results from a Chinese study of remdesivir that was inadvertently posted on the World Health Organization (WHO) website indicated that the drug wasn't effective.
Gilead was quick to publicly respond that the document posted temporarily on the WHO website "included inappropriate characterizations of the study." The company's response also noted that the Chinese study was stopped early because of low enrollment and didn't have enough patients for any meaningful conclusions to be drawn from the study.
All of this drama only intensifies the interest in what Gilead will have to say about remdesivir later this week.
2. Revenue and earnings declines
While remdesivir will likely be the biggest story with Gilead's Q1 update, the main point of a quarterly update is to give financial results. Gilead will probably have some less-than-stellar news on this front.
CFO Andrew Dickinson warned in the company's Q4 conference call in February that the first quarter could be disappointing. He said that total product sales in Q1 would likely decline both on a year-over-year and quarter-over-quarter basis.
Is there a reason for investors to be concerned? Not really. Dickinson pointed out that the U.S. has seasonal inventory patterns and lower buying by public payers that ebb in the early part of the year. Also, sales for cardiopulmonary drugs Ranexa and Letairis will undoubtedly be lower due to generic competition.
It's not surprising, therefore, that the consensus Wall Street earnings estimate for Gilead reflects a drop from both the prior-year period and the previous quarter.
3. A still-massive cash stockpile
Gilead reported $25.8 billion of cash, cash equivalents, and marketable debt securities at the end of 2019. You can rest assured that the company's cash stockpile will still be massive when it announces its Q1 numbers.
But what about Gilead's $4.9 billion acquisition of Forty Seven? It didn't close until early April, so the deal won't impact Gilead's cash position as of the end of the first quarter.
Make no mistake, Gilead's huge amount of cash is still very important. The company continues to explore business development deals, including acquisitions, collaborations, and licensing agreements. It's also committed to increasing its dividend.
Looking to the future
Expect Gilead to highlight key milestones that are on the way in its Q1 update as well. The most important of these is the anticipated U.S. and European approvals for filgotinib in treating rheumatoid arthritis. Gilead also awaits regulatory approvals for CAR-T cell therapy KTE-X19 in treating relapsed/refractory mantle cell lymphoma.
Crickets $$$$$$$$$ Don’t get caught with your pants down buddy
Insiders continued to take advantage of fallen share prices last week. Here are some of the most noteworthy insider purchases reported in the past week.
A director took advantage of a common stock offering to add 1.25 million Carnival Corp (NYSE: CCL) shares. At a share price of $8.00, that cost the director $10.00 million. The stock ended last week's trading at $12.42 per share, which is up 7% or so in the past week but still over 75% lower than at the beginning of the year.
Hmmmm,,,,, Looks like CCL has BUY INDICATOR..... not bankruptcy Rook
Now this totally negates your entire thread!
Wonder why?
Posting BS news hahahahaha
Yawn..... old news rookie,,,,, shorting and nervous now,,,, need some NEW NEWS. Saudi Investment company owns CCL debt
Come on bro( seriously )
Move on with this
I agree.... We don’t need them nor there approval
REMDESIVIR - GILEAD SCIENCES
Antiviral drug, originally developed to combat RNA viruses including respiratory syncytial virus. At least 13 trials underway in China, Europe and the United States with preliminary results expected as soon as May 2020. A February assessment by the WHO flagged this candidate as the most promising for battling COVID-19.
CAVEATS: Initial data are expected to come from studies of patients with relatively severe COVID-19. Because antivirals work best when patients are healthier, those results may show limited effectiveness.
STATUS: Repurposed Experimental
EARLY RESULTS: 0-3 months
FURTHER READING:
Exclusive: Trial of Gilead's potential coronavirus treatment running ahead of schedule, researcher says
Link: https://www.reuters.com/article/us-health-coronavirus-gilead-exclusive/exclusive-trial-of-gileads-potential-coronavirus-treatment-running-ahead-of-schedule-researcher-says-idUSKCN2262X3
Gilead increases enrollment target for remdesivir trial in COVID-19 patients
Link: https://www.reuters.com/article/us-gilead-sciences-stocks/gilead-increases-enrollment-target-for-remdesivir-trial-in-covid-19-patients-idUSKBN21Z25V
Report says COVID-19 patients respond to Gilead's remdesivir, shares surge
Link: https://www.reuters.com/article/us-health-coronavirus-gilead-sciences/report-says-covid-19-patients-respond-to-gileads-remdesivir-shares-surge-idUSKBN21Y3GV
Gilead starts two late-stage studies to test drug for coronavirus
Link: https://www.reuters.com/article/us-health-china-gilead-sciences/gilead-starts-two-late-stage-studies-to-test-drug-for-coronavirus-idUSKCN20K38J
Investors await data on coronavirus drugs as market rally builds
Link: https://www.reuters.com/article/us-health-coronavirus-treatments-stocks/investors-await-data-on-coronavirus-drugs-as-market-rally-builds-idUSKBN21P34G
Gilead asks FDA to revoke orphan drug status for potential coronavirus drug
Link: https://www.reuters.com/article/health-coronavirus-gilead-sciences/gilead-asks-fda-to-revoke-orphan-drug-status-for-potential-coronavirus-drug-idUSL4N2BI4NV
Two thirds of COVID-19 patients improve after Gilead drug: NEJM
Link: https://www.reuters.com/article/us-health-coronavirus-gilead-remdesivir/two-thirds-of-covid-19-patients-improve-after-gilead-drug-nejm-idUSKCN21S24G
Agreed. We are The United States Of America. Can’t depend on the Chinese to do our work for us. We’re smarter than that. Ad the crooks WHO in the mix and now things just became a little more complicated. Doesn’t mean GILD won’t bounce back, might just take some adjusting to get where we need to be.
It does appear that. With new eyes open us,,, 55 plus is very reasonable next week. Most here aren’t selling for beer money. I’m a long!!!!!! GLTA except Shorty $$$$$$$
Great day today. Traded very nicely and plenty of room to run$$$$$$
Enjoy the your weekend and looking forward to seeing what Monday....
Florida will b one that will reopen! Beaches in Jacksonville are ope and businesses will soon follow.
Enjoy the ride. I’m pretty happy with CHEF. Patient is key here
Hahahahaha. Guess the Saudi investment company that bought CCL debt won’t help this Sinking Ship as you claim.
Nice try, post Actually DD and not your Rookie opinions!
Great start to the morning $$$$$$$$
There ya go buddy!!!!! I like your POSITIVE outlooks.... u know we’re on to something big
Hey buddy.......looks like another FALSE NEWS...... this is getting sad here,,,,, Moderator please keep an eye on fake news!!!!! Thank you for all u do
Yep, u beat me to posting it.... great DD,,,,,, keep up the good vibes
Hahahahaha..... Tell em my friend,,,,, Chart is looking beautiful for Longs here,,,,,,, Hey shorty,,,,,, I have your shorts over here$$$$)))
Ups and downs my friend!!!!!!!
I’m riding the wave.... no Reason not too with the potential upside
To me it’s definitely worth the Risk.... here for the long haul.
Entire market is getting slammed today. Just how the cookies crumbles
Best of trades to ya
Lol..... Weeeeeeeee,,,, love a roller coaster ride!!!!!!!!!!
Great.. back to 20 plus dollars $$$$$$$ shorting are ya!!!!!!! Welcome to a fantastic board with lots of GREAT Positive vibes... Welcome
Your kidding Right?
Quote ( News Horrible, Investor’s scared )
I’m ready for your PROFESSIONAL OPINION on how you came to this conclusion
Whatttttttttt.?????????? Actual TRUE statements and not OPINIONS.......No Dr Phil No.... I want you to post bashing... I’m not liking your gentle side///////emoji sad face
Next leg up$$$$$$$$$
Looks like we’re coming out the gates pretty strong $$$$$$$$
Can GILD hold on to the momentum?
Covering? Hahahahaha. Ask Dr. Phil, he’ll have the answer. I just talk to myself on this board!!!!!
Considering April 3rd has came and gone and nothing has been verified I’m not going to read into it.....
Good morning Dr Phil.... What information are you bringing to the BIG BOY BOARD today? Hope you stayed up countless hours discovering more FAKE DD!!!!
Miss u buddy,,,,,, Looking forward to hearing from ya soon
GLTA except to Mr SHORTY!!!!!!!!
First I’ve heard of that. Going to look at the other board to see who’s claiming this!!!! Lots of BS to strike fear to making Longs flip for beer money. I personally haven’t came across anything that states that
It does make one scratch his head. I’m looking for some DD to better understand it myself.
I love it bro!!!!!! I’m locked and loaded$$$$$ Only better days ahead of us!!!!!! Let’s GO. My favorite board by far,,,,,, most are here for the right reasons. Positive vibes folks... makes everything possible. GLTA except shorty!!!!!
I can tell u Most Shorts ARE CYA themselves hahahahaha!!!!!!!
U nervous yet??????
Better find some more garbage post to bring down my CASH COW
Miss you buddy
What a great day here team LONGS!!!!!!! Couldn’t be more happy. Keep up the GREAT DD and ignore the negatives here. If we’re correct, accounts will b filled with $$$$$$$$
Happy Wednesday to all
That’s your job. I’ll only post True DD... until then I remain POSITIVE for $$$$$$$$$
I sense u getting soft on me... I’m not liking your kinder heart!
Better know I’ll b here for FACTs,,,, Not BIG BOY Boards OPINIONS to use as a Scare tactic to profit.
Hahahahaha, best chat room I’ve been writing on in a very long time.
You’ve already posted that. Thanks for the reminder.
I’m patient.... waiting to see what lies ahead. Hoping for the best!!!!!
Step your GAME up. Your starting to get soft on me!
Time to stay GREEN today $$$$$$
Need a lil push to get there! Let’s see how it plays out today $$$$
Yep!!!!! Curious to see what happens here today. Futures are 300 plus before the bell. Good luck to ALL
Appears to be ,,,,,,, Futures are PLUS 300 ...... definitely a positive
Pre market GREEN $$$$$$$
Let’s have a good day today!!!!!
Hate the SHORTs
Here for the LONG!!!!!! Waiting on POSITIVE updates from the company
I want to be the one that makes me the most $$$$$$$ Which one is that?????
LOL,,, let’s have a great day. Early pre market is GREEN